MSAM
JNCE

Moloney Securities Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Moloney Securities Asset Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$451K Sell
2022
Q4 		$536K Buy
2022
Q3 		$298K Sell
2022
Q2 		$544K Sell
2022
Q1 		$1.72M Sell
2021
Q4 		$2.64M Buy
2021
Q3 		$2.1M Buy
2021
Q2 		$113K Sell
2021
Q1 		$201K Buy